Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker

• Status: Not yet recruiting
• Trial end date: 2024-11-01
• Target enrollment: 0
• Participant gender: All

Summary

Aim of work:

To evaluate the effect of stellate ganglion block in prevention of cerebrovascular spasm in traumatic subarachnoid hemorrhage Primary outcome: Asses changes of cerebral blood flow velocity by Trans cranial Doppler.

Secondary outcome: Asses changes in clinical status

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Assiut University
• Treatments: Nimodipine

Criteria

Inclusion Criteria:

1. ASA: I, II

2. Head trauma

3. Hemodynamically stable patient

4. Mechanically ventilated or not

5. SAH diagnosed by CT brain

Exclusion Criteria:

1. relative refusal.

2. allergy to local anesthetic.

3. Any coagulation disorder.

4. Any vascular disease.

5. Penetrating head trauma.

6. Poly traumatized patient.